-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$4.001150% Upside
Biotricity, Inc. Frequently Asked Questions
-
What analysts cover Biotricity, Inc.?
Biotricity, Inc. has been rated by research analysts at H.C. Wainwright in the past 90 days.